Equilateral Ventures is a seed-stage venture firm focused on investing in digital solutions that improve global health and environmental sustainability while generating healthy profits. The firm targets companies at the intersection of healthcare, international markets, and public sectors, leveraging their extensive experience and network in these areas.
Notable portfolio companies include RxAll, a startup combating counterfeit drugs. Equilateral Ventures brings significant value to its investments through its expertise in healthcare, international markets, and public markets. The firm's investment philosophy centers on supporting innovative digital solutions that create positive impact for both people and the planet.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
